Hong Kong Daily Briefing

BCG's global wealth report confirmed Hong Kong has overtaken Switzerland as the world's largest cross-border wealth management hub, driven by a surge in HKEX IPO activity and mainland Chinese HNW capital flows, per SCMP Business. Charles Li, the longest-serving HKEX CEO, separately commented on making Hong Kong a magnet for global IPOs. For equity investors, this structural shift matters beyond the immediate price action: it validates the long-term investment thesis for HKEX itself (Stock Exchange of Hong Kong Ltd), increases the long-term stickiness of AUM in HK-domiciled funds, and supports a premium valuation for Hong Kong-based asset managers and private banks. The Southbound Stock Connect flow data in coming sessions will confirm whether mainland wealth is actively re-entering HK equities.

FinanceAsia HK reported that despite several multi-billion dollar deals announced at the Beijing Xi-Trump summit, analysts are cautioning that major Chinese capital deployment into the US is unlikely in the near term. The friction points: US CFIUS reviews, political optics on both sides, and ongoing tech export restrictions. For Hong Kong as a capital intermediation hub, this matters — if bilateral capital flows remain constrained, the premium that HK commands as a bridge between Chinese capital and global markets may sustain rather than compress. But it also caps near-term catalyst potential from a 'grand bargain' normalisation narrative.

Jardine Matheson is buying I-MED Radiology Network (Australia's largest diagnostic imaging group) from Permira for A$3.4 billion, per FinanceAsia HK. Jardines wants to grow I-MED in Australia and New Zealand. For Hong Kong conglomerate investors, this is a notable strategic pivot: Jardines is diversifying away from pure property/retail exposure (its historical core) into healthcare infrastructure — a sector with demographic tailwinds and AUM-agnostic pricing power. The deal also signals active capital deployment from HK-listed conglomerates into regulated-sector assets with stable cash flows, a sign of institutional confidence in non-China-dependent growth.